How businesses are actually using generative AI
Some experiments with chatbots are more useful than others
Apple is right not to rush headlong into generative AI
One day the Vision Pro could exploit the technology to the full
The battle over the trillion-dollar weight-loss bonanza
Novo Nordisk and Eli Lilly are making blockbuster drugs. Can they maintain their lead?
OpenAI’s legal battles are not putting off customers—yet
Elon Musk, the New York Times and trustbusters all want a piece of the startup
Brain-boosting substances are all the rage
Their utility is debatable
More women are getting onto corporate boards. Good
Our annual measure of the role and influence of women in the workforce
Can Bayer recover from its chronic pain?
The Aspirin-maker is suffering from complications of its acquisition of Monsanto
How can firms pass on tacit knowledge?
The problem of knowing what your co-workers know
Is Saudi Aramco cooling on crude oil?
Don’t bet on it
Can lorries go green faster?
The long road to zero-emission commercial vehicles
|← first ← previous page 8393 of 8652 next → last →|